4th Quarter - Report

MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY for MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY

Firm
Client
Income
—
Expenses
$340,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Medicare/Medicaid and other general health issues

LobbyistCovered position, as disclosed
MICHAEL J EGING —
THOMAS JOHN FUSSARO —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Executive Office of the President (EOP); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Copyright/Patent/Trademark CPT

S. 1145, Patent Reform Act of 2007, entire bill H.R. 1908, Patent Reform Act of 2007, entire bill S. 3600, Patent Reform Act of 2008, entire bill

LobbyistCovered position, as disclosed
MICHAEL J EGING —
THOMAS JOHN FUSSARO —

Contacted: Food & Drug Administration (FDA); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: S. 1145 (110th), S. 3600 (110th), H.R. 1908 (110th)

Health Issues HCR

Issues related to Medicare coverage for certain cancer therapies Issues related to Comparative Effectiveness

LobbyistCovered position, as disclosed
MICHAEL J EGING —
THOMAS JOHN FUSSARO —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Food & Drug Administration (FDA)

Budget/Appropriations BUD

House Concurrent Resolution 312 FY09 Budget Resolution Senate Concurrent Resolution 70 FY09 Budget Resolution Drug Importation Comparative Effectiveness LHHS Appropriations Homeland Appropriations Agriculture Appropriations

LobbyistCovered position, as disclosed
MICHAEL J EGING —
THOMAS JOHN FUSSARO —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Pharmacy PHA

H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection Innovative Biologic Medicine Act of 2007, follow-on biologics H.R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics

LobbyistCovered position, as disclosed
MICHAEL J EGING —
THOMAS JOHN FUSSARO —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); SENATE

Bills named: H.R. 1038 (110th), H.R. 1956 (110th), S. 623 (110th), S. 2029 (110th), H.R. 5629 (110th), S. 1695 (110th), S. 1505 (110th)

Medicare/Medicaid MMM

H.R. 5480, Medicare Funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions 2008 Medicare Bill Comparative Effectiveness H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 S. 3101, Medicare Improvements for Patients and Providers Act of 2008 H.R, Medicare Prescription Drug Price Negotiation Act, Medicare noninterfeence provisions H.R. 1424, Emergency Economic Stabilization Act of 2008 H.R. 3162, Children's Health and Medicare Protection Act of 2007; S. 1893-SCHIP

LobbyistCovered position, as disclosed
MICHAEL J EGING —
THOMAS JOHN FUSSARO —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2029 (110th), S. 2662 (110th), H.R. 1424 (110th), H.R. 5480 (110th), S. 3101 (110th), S. 1893 (110th), H.R. 6331 (110th), S. 3 (110th), H.R. 3162 (110th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.